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ABSTRACT  Secretion  in  Paramecium  is Ca2+-dependent  and  involves exocytic release of the 
content of the secretory  organelle,  known as the trichocyst. The content, called  the trichocyst 
matrix, undergoes  a Ca2+-induced  reordering of its paracrystalline  structure during release, and 
we  have  defined  three  stages in  this  expansion  process. The  stage  I,  or  fully  condensed 
trichocyst, is the 4/~m-long membrane-bounded  form existing prior to stimulation. Stage II, the 
partially expanded trichocyst, we define as an intermediate stage in the transition, preceding 
stage III, the  fully  expanded  extruded  form  which  is a 20-40/~m-long  needlelike  structure. 
These stages have been used to assay the effects  of trifluoperazine (TFP) and W-7, calmodulin 
(CAM) antagonists, on trichocyst matrix expansion in vivo. TFP and W-7 are shown to reversibly 
block matrix release induced by picric acid. Ultra-structural examination reveals that one effect 
of this inhibition is reflected  in the organelles themselves, which are prevented from undergoing 
the stage I-stage II transition by preincubation in 14/xM TFP or 35/~M W-7 before fixation. This 
inhibition of expansion by TFP can be moderated  but not abolished by high extracetlular Ca  2+ 
(5 mM). The  moderation  by high Ca  2+ can  be eliminated  by raising TFP concentration  to 20 
/~M. A possible  explanation for the ability to titrate the inhibition in this manner is that TFP is 
acting to block expansion by binding to the Ca2+-CaM complex.  Brief exposure of cells to the 
Ca  2+ ionophore A23187 and 5 mM Ca  2+ following TFP treatment promotes matrix expansion, 
although  in  14  #M  TFP  a  residual  level  of  inhibition  remains.  These results  suggest  that, 
following  stimulation,  CaM  regulates  secretion  in  Paramecium,  possibly  by controlling  the 
Ca2+-dependent matrix expansion which accompanies  exocytosis in these cells. 
The ciliated  protozoan Paramecium offers an exciting model 
system for studying the control of secretory exocytosis. Thou- 
sands  of membrane-bounded  secretory organdies  known  as 
trichocysts are docked beneath the plasma membrane at spe- 
cific secretory sites in the highly organized cell cortex (18). The 
t'me structure of these organelles has been well characterized 
(2,  15,  16) and  freeze-fracture  studies  have revealed specific 
intramembrane particle arrays in both the plasma and organ- 
elle membranes which are required for secretion (3, 21, 41, 42). 
The trichocysts remain docked in position at the secretory sites 
until a  stimulus triggers release of the vesicle content, which 
will be called the trichocyst matrix, via exocytosis. The protein- 
aceous matrix has recently been found to contain significant 
(1-10%)  amounts  of the  Ca2+-dependent  regulatory  protein 
calmodulin (CAM)  (38).  The role of this matrix CaM, which 
appears  to be  a  structural  part  of the  trichocyst,  is  not  yet 
understood. An essential part of the secretory product release 
in  these  cells  is  an  easily  visualized  transformation  of the 
trichocyst matrix,  from a  highly condensed resting form to a 
greatly elongated secreted form, with an accompanying change 
in its paracrystalline structure. This makes it possible to assay 
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release at the light microscope level,  and concomitant changes 
in the state of the organelle can be monitored with the electron 
microscope. 
As with many other secretory systems (39), external Ca  2+ is 
required  for trichocyst release  (29,  44).  The  role of Ca  2+ in 
secretion  is  not  yet  understood,  but  a  likely  candidate  for 
mediating its action is the Cal-dependent regulatory protein, 
CaM. CaM has been shown to be present  in Paramecium in 
both  cytoplasmic fractions  (41,  45)  and  localized to specific 
cellular structures (28), in addition to being present as a com- 
ponent of the trichocyst matrix itself (13, 38). This ubiquitous 
protein is involved in the regulation of an increasingly larger 
number of Ca2+-regulated events (6, 30, 56) and its involvement 
in the process of secretion has been under investigation in this 
laboratory (10-13, 45) as well as others (1, 8, 9, 23, 33, 47, 50, 
51). 
Initial experiments indicated that preincubation of Parame- 
cium in 14/tM trifluoperazine (TFP), a drug known to inhibit 
CaM-regulated  enzymes  (26),  inhibits  picric  acid  (PA,  the 
routine  stimulus)-induced  trichocyst release  (45).  This  result 
suggests a possible involvement of CaM at some stage of the 
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enzymes  are  known  to  be  regulated  by  CaM  (6,  30,  56), 
numerous pathways are potential targets for TFP action. In 
addition, TFP inhibition alone, while suggestive, is not a firm 
enough criterion to implicate CaM in a cellular process. In this 
report we have used two approaches to address the problem of 
a possible CaM-sensitive step in stimulus-secretion coupling in 
Paramecium. 
First, cells were examined in the transmission electron mi- 
croscope (TEM) to determine whether any manifestations of 
TFP inhibition would  be  evident in  any of the  structurally 
well-defined components of the secretory apparatus, such as 
the secretory organdies themselves. We defme three stages in 
trichocyst  morphology  during  secretion  and  demonstrate  a 
clear ultrastructural correlate to the drug-induced inhibition 
observed in the earlier light microscope study (45).  Second, 
another anti-CaM drug, the naphthalenesulfonamide deriva- 
tive W-7, and its less active dechlorinated analog, W-5 (18-20, 
54), were used to examine whether the inhibition of secretion 
by  TFP  is  due  to  specific interactions  with  the  Ca2+-CaM 
complex, or to nonspecific effects. The results show that effects 
of W-7 are similar to those of TFP in both light and electron 
microscope assays, whereas W-5 has no effect at concentrations 
similar to those of W-7. These results further support a role for 
CaM in the regulation of trichocyst secretion in Paramecium, 
and  in  addition provide  information  as  to  possible sites of 
action for this molecule during exocytosis. 
MATERIALS  AND  METHODS 
Culture Conditions:  Cells  used in all experiments are Paramecium 
tetraurelia,  wild  type,  grown at  27°C  in  bacterized (Enterobacter  aerogenes) 
Cerophyll medium (48). 
Picric Acid-induced  Release:  200 ml of late log phase cultures 
were harvested, washed once in a buffer containing l  mM HEPES, 20 ~M Na- 
Citrate, 20 ~tM CaC12, and 0.5-1.5 mM Tris to adjust pH to 7.0 (HEPES-Citrate 
buffer) (5), and suspended to 10-15 ml in the same buffer. Aliquots of this cell 
suspension were then exposed to TFP, W-7 or W-5 at the indicated concentrations 
in a volume totaling 250 #1. Samples of this suspension were withdrawn at various 
time intervals and rapidly added to a drop of saturated picric acid on a microscope 
slide. PA is a  secretagogue routinely used to induce trichocyst release in Para- 
mecium  (36).  Ceils  were  then  scored for release (more than or less than  50 
trichocysts per cell) with a Wild light microscope equipped with phase-contrast 
optics.  TFP,  W-7,  or W-5  was dissolved  in  distilled,  deionized  water (stock 
solutions: TFP,  1 mM; W-7 and W-5, 5  mM) and stored in small aliquots at 
-20°C. In experiments where drug exposure was carried out in the presence of 
high (5  raM) Ca  2+,  a  sufficient amount of a  stock solution (0.5  M  CaC12  in 
HEPES-Citrate buffer) was added directly to the cell suspension immediately 
before  drug addition.  Raising the  Ca  2+  concentration to  5  mM  during W-7 
exposure was achieved by adding a small volume of this stock Ca  2. solution so 
that drug dilution was minimal. All incubations were performed at room tem- 
perature. 
Reversal of TFP-induced inhibition was achieved by diluting the sample (200 
#1)  to  5  ml  with  HEPES-citrate buffer containing  10%  bacterized  cerophyll 
medium. After 5 min the cell5 were pelleted in a  clinical centrifuge, the buffer 
removed  except  for  -250-300 /d  in  which cells were  resuspended by gentle 
agitation. Samples were taken from this suspension and scored for trichocyst 
release as described. 
For electron microscope observations, 400 ml of late log phase cultures were 
harvested, washed as for the light microscope studies, and suspended to 20 ml in 
HEPES-citrate buffer. Aliquots of this cell suspension were then exposed to TFP, 
W-7, or W-5 at the indicated concentrations for varying times before fixation. 
Controls (no drug addition) received equivalent amounts of water. Ca  2+ concen- 
tration was raised as in the light microscope experiments, by addition of a small 
volume  of 0.5  M  CaCI2  in  HEPES-citrate  buffer  immediately  before  drug 
exposure. The final volume of cell suspension, CaCI2 (if added), and drug was 
always 1 ml. All incubations were performed at room temperature. 
For treatment of cells with Ca  2+ ionophore, a  I mM stock solution of A23187 
in dimethylsulfoxide (DMSO) was prepared, which was diluted to the working 
concentration ( 100 ~tM) in HEPES-citrate buffer: Cells were prepared as described 
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above, and incubated in either 8 or 14/tM TFP for 10 rain in a volume of 850 
/d. After 10-rain exposure, 150/d of 100/tM A23187 was added rapidly, to a final 
volume of I ml (final A23187 concentration, 15/LM) and final DMSO concentra- 
tion of <2%. Control ceils exposed to this concentration of DMSO were indistin- 
guishable from untreated controls. A23187 exposure was carried out for 60 s at 
room temperature. 
Electron Microscopy:  Cells were fixed at the indicated times by rapid 
addition of I ml of osmium tetroxide (final concentration 0.5%) for 20 s, followed 
by 2 ml of 4% glutaraldehyde (final concentration 2%) for 1 h  at room tempera- 
ture. 
Fixed cells were washed twice in  HEPES-citrate  buffer and processed for 
TEM. Cells were stained en bloc for I h in 1% aqueous uranyl acetate followed 
by alcohol dehydration and embedding in Epon-Araldite or Epon. Thin sections 
were cut on an LKB 8801/2 (LKB Instruments, Inc., Gaithersburg, MD) or a 
Reichart ultramicrotome and stained with 4% uranyl acetate in 40% ethanol for 
30 rain, followed by lead citrate (55) for 10 min at room temperature. Electron 
micrograpbs were taken with either a  Seimens  1A or a  JEOL  100CX electron 
microscope. 
Quantitation of Electron  Micrographs:  Micrographs  for quan- 
titation were taken at magnifications ranging from x  1,500 to 2,500, depending 
on size and orientation of the ceil section, to obtain the entire cell section in one 
or two micrographs. Negatives were then further enlarged x  2.5. The images 
were scored by counting trichocyst profiles, determining the number of  condensed 
(I) and expanded (II and III) stakes, and calculating the percentage of trichocysts 
in each stage per ceil. Stage I1 (partially expanded) and stage 11I (fully expanded) 
trichocysts were considered a single category, because stage III trichocysts inside 
the ceil were only seen infrequently. 
RESU LTS 
Effects of Trifluoperazine and W-7 on Picric 
Acid-induced Release 
Secretion of trichocysts induced by PA is inhibited when 
Paramecium  ceils are incubated in buffer containing TFP (47; 
Fig. 1 a). Exposure of cells to 16/~M TFP (Fig. I a) results in a 
gradual decrease in the number of cells exhibiting a  normal 
level of trichocyst release. After 15 min of drug exposure, ~35% 
of cells are releasing more than 50 trichocysts per cell (Fig. I a, 
arrow). Dilution of the drug at this point (final concentration 
<1 #M TFP) results in recovery of secretory capacity, following 
a  lag time of 10 min during which the inhibition progresses 
further. The reason for the continued inhibitory effect of TFP 
after dilution of the drug is not clear, but recovery is evident 
within 15 rain of dilution, and near control levels of secretion 
are achieved 30-45 min after dilution of TFP. 
Inhibition of secretion is  also  seen  following exposure  to 
another anti-CaM drug,  the naphthalenesulfonamide deriva- 
tive, W-7 (18,  19), (Fig. 1 b). Cells exposed to 35/~M W-7 in 
HEPES-citrate  buffer  (20  #M  Ca  ~÷)  show  rapid  inhibition 
(within  1  min)  of PA-induced trichocyst  release.  5  min  of 
exposure to W-7 (35/~M) in low Ca  2÷ (20 #M) results in 80- 
90%  inhibition of trichocyst release.  However,  most  of this 
inhibitory effect of W-7 can be prevented if the drug exposure 
is carried out in the presence of high Ca  2÷ (5 mM) (Fig. I b). In 
addition, inhibition of secretion induced by W-7 (35  /~M) is 
rapidly reversible following addition of Ca  2÷ to a final concen- 
tration of 5 mM (Fig. I b, arrow). 2 min after Ca  2÷ is raised to 
5  mM,  50%  of the  ceils tested  are  secreting more  than  50 
trichocysts per cell. This recovery appears to plateau at ~75% 
after 7  min of exposure to the increased Ca  2÷.  Interestingly, 
this level of cells secreting normally following Ca2÷-induced 
recovery is similar to that of cells exposed to W-7 in high Ca  2+ 
from the start of the experiment. 
W-5, structurally very similar to W-7, but with much lower 
alTmity for CaM (20, 54), has no effect on trichocyst release at 
a concentration of 50 #M (Fig. I b). 
These results show that two different CaM antagonists are 
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FIGURE  1  Effect of CaM antagonists on PA-induced secretion. Tri- 
chocyst  release was assayed at the  light  microscope.  (a)  Cells ex- 
posed to  16 p.M  TFP  in  HEPES-citrate  buffer  (20 p.M  Ca2+).  At  the 
arrow, the sample was diluted  to 5  ml  (TFP, <1  p.M). The dashed 
portion  of  the  curve  indicates  the  time  during  which  cells  were 
centrifuged  and  resuspended. Closed diamonds:  16 p.M  TFP; open 
diamonds; <1 p.M TFP after washout. (b) Cells exposed to 35 p.M W- 
7  in  HEPES-citrate  buffer  (20 p.M  Ca  2+)  (open  diamonds),  or  in 
HEPES-citrate buffer +  5 mM Ca  2+  (open triangles). At arrow, Ca  2÷ 
concentration was raised from 20 p.M to 5 mM (without significant 
drug dilution) and cells recover secretory capacity (closed triangles). 
50p.M W-5  (open squares) in HEPES-citrate buffer (20/zM Ca  2+) has 
no effect. 
capable of inhibiting trichocyst release in Paramecium.  These 
data,  in  addition  to  the  differential effect  of the  W-7/W-5 
analogs, suggest that CaM is involved at some stage of exocy- 
tosis in these cells. It therefore became important to examine 
whether there were any observable effects of these drugs at the 
ultrastructural level on the secretory organelles themselves or 
related structures. 
Three Stages of Matrix Expansion 
Fig.  2  shows  examples  of the  three  hypothesized  stages 
defining  the  sequence  through  which  the  trichocyst  matrix 
passes from stimulation to final release into the medium. Fig. 
2a  shows  the  in  vivo trichocysts prior to  release docked in 
position under  the  cell membrane  in  between  two  adjacent 
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alveolar sacs. Earlier descriptions of this form of the trichocyst 
(2, 16) identified it as the mature form of the organdie. At this 
stage the trichocysts are characterized by their uniform shape 
and size, ~4 #m in length and 0.9 #m in width. The membrane 
FiGUrE  2  The  three  hypothesized  stages  defining  the  sequence 
through which the trichocyst matrix passes from stimulation to final 
discharge. (a) Stage I, fully condensed; (b) stage II, partial expansion; 
(c)  stage  III,  full  expansion.  Insets  show trichocyst  stages  as they 
appear in phase contrast  microscopy.  (a-c)  Bar, 5 #m.  (Inset  to a) 
Bar, 1 p.m. (a) x  2,000; (inset)  x  12,480. (b) x  2,000; (inset) X 16,340. 
(c)  x  2,000;  (inset)  x  16,950. surrounding the trichocyst matrix is clearly visible. The ultra- 
structural characteristics of the trichocyst matrix itself can be 
subdivided into the lower two-thirds consisting of the broader 
body region and the upper one-third consisting of the conical 
tip. The tip region mediates the insertion of the organdie into 
its secretory site,  and the tip itself remains unchanged during 
the entire release event. The body of the resting trichocyst is 
electron-dense and appears crystalline, exhibiting regular trans- 
verse dense lines spaced at ~7-nm intervals as reported earlier 
(16).  These  resting  trichocysts  will  be  referred  to  as 
"condensed" or stage I trichocysts. 
The  inset of Fig.  2a  shows the light microscope image of 
such isolated,  stage I  trichocyst matrices.  Homogenization of 
Paramecium in the presence of Ca  2+ chelators yields prepara- 
tions enriched in stage I trichocysts, allowing direct observation 
of this  form of the organelle.  They appear phase-dense,  and 
their  characteristic  tip  and  body features  make  them  easily 
recognizable even at this low magnification. 
Upon stimulation  for release,  the  matrix  of the  trichocyst 
undergoes a  reorganization to form a  20--40-~tm-long  needle- 
like,  paracrystalline  structure,  with  a  distinct  and  increased 
periodicity of ~55  nm (nearly eight times that of the resting 
stage)  (2,  15,  50).  An example  is shown in  Fig.  2c.  The tip 
maintains its characteristic morphology but now surmounts a 
greatly elongated body. This structure is the secreted form of 
the matrix, normally found outside the cell, and will be referred 
to as the "fully expanded" or stage III trichocyst. The inset of 
Fig. 2 c shows the corresponding image in phase-contrast mi- 
croscopy, which again is characteristic and easily distinguished. 
Fig. 2 b shows the predominant form of the trichocyst matrix 
visualized following routine  fixation of cells for electron mi- 
croscopy. The majority of trichocysts observed within  Para- 
mecium cells fixed for TEM can be seen to have undergone (a) 
an increase in size from 4 #m to 8-12 pm in length, and from 
0.9 #m to  1.2/tm in width,  and (b) a  loss in electron density 
and paracrystalline order. The inset of Fig. 2 b again shows the 
corresponding phase  microscope appearance  of this  form as 
illustrated by isolated trichocysts matrices. 
A number of observations suggest that this form, which we 
call the "partially expanded" or stage II trichocyst, represents 
an  intermediate  stage  in the  transition  from the  condensed, 
resting form (stage  I) to the fully expanded form (stage III). 
Images of trichocysts exhibiting all three stages of expansion in 
succession  down  their  length  can  be  found  (Fig.  3)  (also 
reference  17). The portion of the body closest to the tip  has 
undergone a transition to stage III, a small segment deeper in 
the cell is in stage II, and the most distal portion of the body 
remains  in  stage  I.  Images  such  as  these  suggest  that  the 
transition of the matrix from stage I to stage III passes down 
the body of the trichocyst like  a  wave: stage  I  progresses to 
stage II and then stage III as matrix reorganization proceeds 
down the length of the organelle in response to a spatial and 
temporal gradient of stimulation. 
In Paramecium, as well as in other cells, low concentrations 
of fixatives  can  serve  as  secretagogues  (2,  35,  43)  eliciting 
complete release  of secretory products.  It is probable that at 
higher  concentrations,  such  as  those  used  here,  the  release 
process,  which in  Paramecium  includes  matrix  expansion,  is 
initiated but proceeds only to an intermediate stage (II) before 
fLxation  occurs. Inhibition of trichocyst discharge can be in- 
duced with potassium ferrocyanide which has been shown to 
generate a number of  inhibited states, one of which corresponds 
to stage II. Hausmann et al.  (16)  called this form a  "type II" 
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FIGURt  3  TFM  image  of  a  single  trichocyst  exhibiting  all  three 
stages of the trichocyst matrix. The tip remains unchanged, and the 
body consists of matrix in stages III, II, and I ordered consecutively 
from tip to base of the organelle. Bar, 0.5/Lm. x  19,800. 
TABLE  I 
Requirements for PA-induced Release and Osm/glut-induced 
Expansion 
Osm/glut-in- 
PA release  duced expansion 
Extracellular Ca  2÷  Required  Required 
High extracellular Mg  2+  Inhibits  Inhibits 
Slow cooling  Inhibits  Inhibits 
TFP  Inhibits  Inhibits 
W-7  Inhibits  Inhibits 
trichocyst  and  suggested  that  it  might  represent  a  stage  of 
discharge. 
A  comparison  of requirements  for  PA-induced trichocyst 
release and fixative-induced partial expansion to stage II sug- 
gests that both stimuli are eliciting the same cellular response. 
Table I shows that both the I-II transition and complete release 
(I-III) require extracellular Ca  ~+, are inhibited by high extra- 
cellular Mg  2+, slow cooling, and the anti-CaM drugs TFP and 
W-7. The similarity of response to a variety of different treat- 
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by PA (also a fixative) invokes the same cellular processes, but 
the more rapidly acting fixatives will arrest matrix reorgani- 
zation  at  the  intermediate  stage  we  call  stage  II.  Thus,  the 
formation  of stage  II trichocysts  is  indicative  of the  initial 
events leading to secretion, and monitoring the effects of  agents, 
such as TFP, on stage II formation should allow dissection of 
early cellular events following stimulation. 
Effect of TFP on Matrix Expansion 
This hypothesis forms the  basis for the ultrastructural  ap- 
proach to the question of CaM involvement in secretion de- 
scribed  in  the  following  experiments.  To  test  whether  the 
observed TFP inhibition of PA-induced release might be re- 
flected in the structural components of the secretory apparatus, 
we exposed late log phase cells  to the CaM inhibitor TFP (14 
#M) for 0-10 min. Cells were fixed at different timepoints and 
examined in the TEM. Fig. 4 a shows a control cell exposed to 
buffer only. In this case, virtually all of the trichocysts are in 
the partially expanded state (stage II). Trichocysts are shown 
sectioned  both  longitudinally  (arrows)  and  in  cross  section 
(arrowheads). Although the trichocyst tips are for the most part 
out of the plane of section in this cell, several tips are visible in 
a number of longitudinally sectioned organdies (*).  It is clear 
that trichocysts are docked in their correct places beneath the 
cell membrane. 
Fig. 4 b  shows an example of a  Paramecium cell  after a  3- 
min exposure to TFP which leads  to a  slight increase  in the 
number  of stage  I  trichocysts;  a  few  images  of condensed 
trichocyst matrices are now evident. After 5 min of exposure 
(Fig. 4 c), -50% of the trichocysts remain condensed (stage I). 
This effect is progressive and Fig. 4 d shows a sample cell after 
10-min  of exposure  to  TFP  which  causes  nearly  complete 
inhibition of matrix expansion, that is, the majority of tricho- 
cysts are now found in stage I. 
The intimate relationship of the trichocyst tip to the plasma 
membrane appears unaltered after TFP treatment. Condensed 
stage 1 trichocysts seen after TFP exposure remain docked in 
position  between  the  alveolar  sacs,  with  the  trichocyst  tip 
membrane close to (but not fused with) the plasma membrane, 
identical to stage II trichocysts seen in control cells. Therefore 
the increase in condensed trichocysts cannot be accounted for 
by any gross alteration  in organelle-plasma  membrane  rela- 
tionship, nor by an increase in undocked trichocysts. 
The rise in the percentage of stage I trichocysts is not due to 
an  overall  depletion  of trichocysts  resulting  from  increased 
release induced by TFP. If this were the case, a fixed number 
of stage I  trichocysts would comprise a  higher percentage of 
the  total  trichocysts  remaining  in  each  cell,  thus  giving  an 
artificial  impression  of an  increase  in  the  condensed  form. 
Table II indicates that the average number of trichocysts in the 
cell  sections  counted does not decrease  following  10 min of 
TFP exposure. Thus, the increase in stage I trichocysts per cell 
occurs in cells  exhibiting a  fairly constant level of trichocysts 
FIGURE  4  TEM  images  of  Paramecium  cells  exposed  to  14/~M  TFP,  low  extracellular  Ca  2+  (~20 p,M).  (a)  Control  cell,  no TFP 
exposure. (b)  3  min.  (c)  5 rain.  (d)  10 min.  Bar, 5gin.  a, x  2,400.  b, x  2,250.  c,  x  2,960.  d,  x  2,400. 
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treatment. 
It thus became of interest to us to test if the inhibitory effects 
of TFP  would  be  affected  or  overcome  by  increasing  the 
external Ca  2+ necessary to drive the expansion of the trichocyst 
matrix. Paramecium cells were therefore exposed to 14 #M TFP 
in  the  presence  of a  5-raM  concentration  of external  Ca  2+. 
Examination  of these  cells  in  TEM  reveals  that  TFP  still 
inhibits matrix expansion,  although  the  inhibition is not  so 
complete as in low Ca  2+. Fig. 5 a shows a control cell exposed 
to 5 mM Ca  2÷ but not to TFP. In this case, nearly all trichocysts 
are  partially expanded  (stage  II).  The  remaining  Fig.  5 b-d 
demonstrate the extent of TFP-induced inhibition of expansion 
in the presence of high Ca  2+. Again, with increasing time of 
TABLE  II 
Numbers of Trichocyst  Profiles per Cell Section Scored in 
Untreated Cells,  and Cells Exposed to TFP under Various 
Conditions for 5 and 10 rain 
Conditions  Control  5 rain  10 rain 
14 #M  TFP, low  111.6  (:t:5.5)  73.8  (+5.9)  97.4  (±5.7) 
Ca  2+ 
14  #M  TFP,  5  86.3  (±19.3)  91.3  (±14.7)  I01.8  (±14.9) 
mM Ca  2+ 
20  /~M  TFP,  5  76  (±8.1)  86.4  (±15.7)  94.3  (+12.5) 
mM Ca  2+ 
incubation, the drug leads to an increase in the number of stage 
I trichocysts visible in each cell. Cells after l0 min of exposure 
to TFP, as shown in Fig. 5 d, have  ~50% of their tdchocysts 
remaining in stage I. Expansion is therefore dearly inhibited 
but not to the same extent as the case where the external Ca  2+ 
concentration was low (~20 #M), seen in Fig. 4d, where >90% 
of the trichocysts remain condensed. 
The moderating effect of high extracellular Ca  2+ is shown 
quantitatively in  Fig.  6 a.  It is evident from  this graph  that 
exposure to 14 #M TFP in both the low (~20/tM) and high (5 
raM) Ca  2+ conditions leads to a  decrease in the percentage of 
expanded trichocysts per cell. The presence of 5 mM external 
Ca  2+, however, reduces this inhibitory effect of TFP. The sharp 
drop  in  the  number  of expanded  trichocysts  per  cell  seen 
between  3  and  5  min  in  low extracellular Ca  2+  and  TFP  is 
tempered by addition of high external Ca  2+, and the level of 
trichocyst expansion seen after l0 min of TFP exposure in high 
Ca  2÷  is approximately ten  times that  seen  in  low  Ca  2+  and 
TFP. The percentage of expanded stage II trichocysts per cell 
after 5  and  l0 rain of TFP treatment  in both low and high 
external  Ca  2÷  is  significantly different  from  that  in  control 
samples. 
If the effects observed on trichocyst matrix behavior are real 
biological manifestations it should  be  possible to  titrate the 
moderating effect seen in the presence of 5 mM external Ca  2+ 
by increasing the concentration of TFP, thereby converting the 
high Ca  2+ situation into the low Ca  2+ case. An experiment was 
FiGure  5  TEM  images of  Paramecium  cells exposed to  14 #M  TFP, high  extracellular Ca  2+  (5  mM).  (a)  Control  cell,  no TFP 
exposure. (b) 3 rain. (c)  5 rain. (d)  10 min. Bar, 5 p,m. a, x  3,000. b, x  3,500. c, x  3,500. d, x  3,400. 
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(a)  The  effect  of  extracellular  Ca  2+  concentration  on 
inhibition of matrix expansion by TFP. Increasing extracellular Ca  2+ 
moderates the inhibition of expansion by 14#M TFP. (b) The effect 
of  increasing TFP concentration on  inhibition of  matrix expansion 
in  high  extracellular Ca  2+  (5  raM).  Increasing  TFP  concentration 
from  14-20/tM  overcomes the moderating effect of  high extracel- 
lular Ca  2+. 
performed in which the TFP concentration was raised to 20 
#M  and  the  Ca  2+  concentration kept as before (5  mM);  the 
results are shown graphically in Fig. 6 b. It is evident that even 
in  the  face  of a  large  inward  gradient  of Ca  2+  ion  during 
stimulation, a slight increase in drug concentration can restore 
the level of condensed stage I trichocyst matrices to nearly that 
seen in the absence of added Ca  2+ (Fig. 6 a). This antagonistic 
relationship between TFP and Ca  2+ ion suggests that TFP is 
acting specifically  to block Ca  2+ action, possibly by affecting a 
CaM-dependent process which may be necessary for Ca  2+ to 
drive matrix expansion. 
Another stimulus which has frequently been used to induce 
secretion in numerous  secretory systems (37,  57),  and which 
induces trichocyst release in Paramecium (34, 44), is the Ca  2+ 
ionophore A23187. The effect of this secretagogue was tested 
to determine whether an ionophore-induced rise in intracellular 
Ca  2+  concentration  alone  could  override  the  TFP-induced 
inhibition of expansion. Cells were therefore exposed to TFP 
for l0 min at concentrations which block trichocyst expansion 
(8 and  14/~M) followed by brief treatment (60 s) with  15 #M 
A23187.  The  results  of such  experiments  are  shown  in  the 
histogram (Fig. 7).  Exposure of cells to 8/xM TFP for 10 min 
in the presence of 5 mM Ca  2+ results in inhibition of trichocyst 
expansion to ~60% of the control value. Another cell sample 
given identical TFP treatment but followed by 60-s exposure 
to the Ca  2+ ionophore A23187 shows trichocyst matrix expan- 
sion returning to control levels. 
Cells incubated in a  higher concentration of TFP (14 #M) 
show an even greater reduction in the percentage of expanded 
stage II trichocysts per cell (Fig. 7).  Subsequent exposure of 
these cells to A23187 (15/xM) promotes a substantial expansion 
(~50%) of the TFP-induced stage I trichocysts to stages II and 
III (Fig. 7). However, the level of expanded trichocysts per cell 
under  these  conditions is  only  ~70%,  which  is  significantly 
depressed compared to control levels. 
Therefore, it appears that at lower concentrations of TFP (8 
#M),  brief treatment of cells with ionophore can reverse the 
inhibition  of matrix  expansion  completely,  but  when  TFP 
concentration is raised to  14  #M  ionophore stimulation can 
return  the  level of expansion to  ~70%  of the  control value, 
leaving a residue which remains in stage I (~25%). Thus, Ca  2+ 
entering  cells via  the  ionophore  is capable of reversing the 
TFP-induced inhibition to a  large degree, although the effec- 
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tiveness of ionophore stimulation also appears to be antago- 
nized by increasing concentrations of TFP. 
Effect of W-7 on Matrix Expansion 
The CaM antagonist W-7 (18, 19) which inhibits picric acid- 
induced  release  (Fig.  l)  also  inhibits  the  trichocyst  matrix 
expansion to  stage  II seen  following fixation (Fig.  8).  Cells 
were exposed to 35/~M W-7 for l0 min in l mM Ca  ~+ prior to 
osm/glut  fixation.  The  effect  of pretreatment  with  W-7  is 
similar to that seen with TFP, trichocyst expansion is inhibited, 
and  most  matrices  remain  in  stage  I  (Fig.  8).  Control  cells 
without drug treatment are equivalent to those seen in Figs. 4 a 
and 5 a. 
Thus, two CaM antagonists, TFP and W-7, exhibit parallel 
effects on both secretion stimulated by picric acid (Fig. l) and 
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FIGURE  7  TFP treatment followed by Ca  2+  ionophore A23187. TFP 
exposure was carried out at the indicated concentrations for 10 min. 
Samples not treated with A23187 were then fixed immediately, while 
companion samples given identical TFP exposure were treated for 
60 s with 15 p,M A23187 prior to fixation. TFP inhibits matrix expan- 
sion in a dose-dependent manner. Subsequent exposure to A23187 
can promote matrix expansion to control  levels when TFP concen- 
tration  is  low  (8 #M),  and  promote substantial expansion  (70% of 
the control)  in the presence of 14/.tM  TFP. 
FIGURE  8  TEM  image of  Paramecium  cell exposed to 35/LM W-7 
(1  mM  Ca  2÷)  for  10  rain.  (Arrows)  Stage  I  trichocyst  matrices. 
(Arrowheads) Stage II matrices. Bar, 5 #m. x  2,400. matrix expansion occurring after osm/glut fixation (Figs. 4, 5, 
and 8). 
DISCUSSION 
Picric Acid-induced Release 
In this report we have shown that two different drugs known 
to  bind to  CaM  and  inhibit its actions (18,  19,  26,  27)  will 
reversibly inhibit picric acid-induced release of the secretory 
organelle  content  of Paramecium  (Fig.  1).  The  kinetics  of 
inhibition by the two drugs appear to be different judging from 
the graphs in Fig. 1. However, the decrease in secretory capacity 
is variable, with some experiments exhibiting faster or slower 
kinetics than the graphs shown. This variation may be due to 
slight differences in cell density, culture age, or residual Ca  2÷ 
concentration, and does not appear to reflect different mecha- 
nisms of action for the two drugs. Clearly, the results always 
indicate inhibition of release with longer exposure to either W- 
7 or TFP. 
There  are,  however,  some  differences in  the  responses  of 
Paramecium  to  the  two  anti-CaM  drugs.  The  recovery  of 
secretory capacity following TFP exposure occurs more slowly 
and cannot be achieved by simply raising the Ca  2÷ concentra- 
tion, as in the case of W-7 (Fig. 1). TFP has a higher affinity 
for Ca2÷-CaM complexes than W-7 (Kd =  1 vS.  11  /~M) (19, 
27), which may slow its removal from the cell. The rise in Ca  2÷ 
concentration alone may be insufficient in reversing TFP in- 
hibition  because  of at  least  two  effects  of the  drug:  (a)  its 
specific binding to CaM and (b) nonspecific membrane effects 
resulting from its inherent hydrophobic properties (24). Raising 
the Ca  2÷ concentration may overcome the specific inhibition 
of CaM, as suggested by the results from W-7 treatment, but 
this by itself may not be sufficient to overcome the possible 
nonspecific effects of exposure to  TFP.  However,  if Ca  2÷ is 
present from the start of TFP exposure it greatly reduces the 
extent of inhibition of secretion caused by the drug (Fig. 6). 
The same protection via Ca  2÷ can be observed in W-7 experi- 
ments (Fig. 1). 
The differential effects of the W-7/W-5 pair of drugs offer 
further support for a direct effect on CaM activity. These two 
drugs differ only slightly in structure but the affinity of W-7 
for CaM is five- to sixfold greater than that of W-5 (20,  54). 
The ability of W-7 to inhibit secretion at concentrations where 
W-5 has no effect strongly suggests that the drug is acting by 
interfering with a CaM-mediated process. 
Three Stages of Matrix Expansion 
We have defined three distinct stages in the expansion and 
release of the secretory organelle content of Paramecium. Using 
these  stages,  we  propose  a  morphological sequence  for  the 
trichocyst matrix expansion. The structural reorganization of 
the trichocyst matrix has been examined (2,  15,  16, 46), and it 
was determined that the phase and electron-dense, fully con- 
densed trichocysts, here defined as stage I, represent the true 
mature form of the organelle existing in vivo prior to stimula- 
tion. This form is converted by a rearrangement of preformed 
elements into stage III, the fully expanded trichocyst during 
the expansion process that normally accompanies extrusion (2, 
15). The partially expanded trichocyst, which we call stage II, 
has also been observed and discussed by a number of authors 
(2,  16). Forms similar to this were seen in studies using potas- 
sium ferrocyanide to inhibit expansion (16).  Detailed studies 
of trichocyst expansion  (16,  17,  46)  suggest  that  the  matrix 
reorganization occurs via unfolding of tightly packed fdamen- 
tous structures to form a more loosely packed matrix of a new 
periodicity. It is reasonable to suggest that during the unfolding 
process  there  may  exist  a  brief transitory period when  the 
periodicity is not clearly visible. This is strongly suggested by 
images  such  as  Fig.  3  (also  reference  17)  where  the  small 
segment of the matrix which is in stage II is interposed between 
stage I and stage III, as if it is a region of transition. 
Fixatives such  as  osm/glut  and  picric acid can  stimulate 
secretion (43); cold osmium tetroxide (2) or low concentrations 
of glutaraldehyde (<1%)  (35)  will elicit complete release of 
trichocyst matrices.  At  higher  concentrations,  such  as  those 
used in this study, it is probable that stimulation of release by 
osm/glut  is  countered  by  more  rapid  fixation,  halting  the 
process of matrix expansion for the  majority of cases at an 
intermediate stage (stage II). It would appear that the unfolding 
process of the matrix has begun,  but in most cases fLxation 
occurs before full reorganization to stage III matrix can occur. 
It is possible that in the normal process of release of trichocysts 
the entire matrix is never actually in stage II all at once but 
proceeds  very rapidly via stage  II  to  stage  III as  extrusion 
occurs. In this sense the stage II trichocyst is somewhat artifac- 
tual, but we postulate that the molecular events which occur to 
produce  stage  II  are  indicative  of the  early  events  in  the 
reorganization of the trichocyst matrix. 
The  transition  to  stage  II  trichocysts can  be  blocked  by 
treatments  which  also  block  secretion,  such  as  high  Mg  ++ 
concentration (15a, 44),  slow cooling of cells, and,  as shown 
here, treatment with the anti-CaM drugs TFP and W-7 (10-12, 
45). Inhibition of expansion from stage I to stage III (release of 
trichocysts), and from stage I to stage II by identical treatments, 
suggests either that they have common requirements, or rep- 
resent the same pathway. We suggest that stage II trichocyst 
matrix  represent an  intermediate form  and  not  an  alternate 
form  since  images  of single  trichocysts exhibiting all three 
stages in succession along their length can be found (Fig. 3; 
reference 17). 
Effect of CaM Antagonists  on Matrix Expansion 
Paramecium cells preincubated in TFP or W-7 are blocked 
from promoting trichocyst matrix expansion when fixed (osm/ 
glut  =  stimulus).  The  lack of matrix  expansion  is a  visible 
indication that TFP and W-7 apparently have interrupted the 
chain of events leading to exocytosis, perhaps by interfering 
with CaM-activated cellular events. These results provide cor- 
roboration for the inhibition of picric acid-induced trichocyst 
release by TFP and W-7 observed at the light microscope level 
(47; Fig. 1). The ultrastructural manifestation of this inhibition 
shown here represents the first clear manipulable demonstra- 
tion of the effect of CaM  antagonists on components of the 
Ca2+-sensitive exocytic machinery. 
The mode of action of TFP and W-7 has been shown in vitro 
to be a  Ca2+-dependent binding to a hydrophobic site on the 
CaM molecule (25, 26,  53-54). The resulting Ca2+-CaM-drug 
complex is then incapable of interacting with and activating its 
target enzymes. Currently, this reaction has not been shown to 
occur in vivo, although W-7 has been localized throughout the 
cytoplasm, similar to CaM (20). Phenothiazines in general, and 
TFP in particular, have been shown to bind to other cellular 
proteins (7, 31), and could also be interfering with lipid-enzyme 
interactions due  to  their hydrophobic nature.  However,  the 
ability to block secretion and matrix expansion with a  struc- 
turally different CaM antagonist provides stronger support for 
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of CaM function. 
The  ability to  titrate  the  inhibition  by  altering the  Ca  2+ 
concentration also fits predictions based on the model of the 
"TFP shunt" proposed by Satir et al. (45). This model suggests 
that  increasing the  available Ca  2÷  should moderate, but not 
abolish, the inhibitory effect of CaM antagonists. Higher intra- 
cellular Ca  2÷ concentration following stimulation will create a 
greater "poor' of Ca2+-CaM, which, when drug concentration 
is held constant, will lead to a  higher percentage of activated 
enzyme complexes and a moderation of TFP or W-7 inhibition. 
An assumption inherent in this model is that within the cell 
the concentration of CaM exceeds that of TFP, so that excess 
CaM is available to form Ca2+-CaM complexes when intracel- 
lular Ca  2+ is raised. 
A moderation of inhibition is indeed what we see in the case 
of trichocyst expansion (Fig. 6 a).  A  similar moderation was 
reported by Kanamori et al. (22).  These authors  found that 
relaxation of rat aortic strips induced by W-7 could be partially 
reversed by the addition of excess extracellular Ca  2÷. 
Another prediction of the "TFP shunt" is that increasing the 
concentration of CaM antagonists will counter the moderating 
effects of increased Ca  z+ concentration. Ca  2÷ and TFP or W-7 
should work in opposition, with Ca  2÷ driving the formation of 
Ca2÷-CaM complexes, and the drugs acting to lower the avail- 
ability of these complexes for interaction with target enzymes. 
The results shown in Fig. 4 b clearly demonstrate that increas- 
ing the TFP concentration from  14  to  20 gM  abolishes the 
moderating effect of high extracellular Ca  2+ on the inhibition 
of trichocyst expansion; most organdies now remain in stage 
I. Therefore, the second prediction of this model is satisfied. 
While this evidence is not conclusive proof of a role for CaM 
in trichocyst release, it is hard to account for these results by 
any other model. For instance, CaM antagonists might simply 
be inhibiting Ca  2÷ entry into cells, so that stimulation does not 
lead to a  rise in intracellular Ca  2+ concentration sufficient to 
promote expansion. Results from a study of the effects of CaM 
antagonists on swimming behavior in Paramecium suggest that 
intracellular Ca  2÷  increases following exposure  to  the  drugs 
(35a). This would suggest that Ca  2÷ is present in the cytoplasm 
but unable to activate events leading to matrix expansion and 
secretion. This is also suggested by the results of experiments 
in which the Ca  2+ ionophore A23187 was used to raise cyto- 
plasmic  Ca  2÷  directly and  thereby  stimulate  secretion.  The 
effects of exposure to 8 gM TFP are completely overcome by 
the ionophore, but when TFP concentration is raised to 14/~M 
a small but significant level (~25%) of inhibition remains even 
after ionophore stimulation (Fig. 7). 
Possible Sites for Calmodulin Action 
Where does CaM act in regulating trichocyst expansion and 
secretion? A possible sequence of events involved in trichocyst 
release appears to be: (a) an influx of extracellular Ca  2+, raising 
cytoplasmic Ca  2+ >10  -6 M, (b) formation of Ca2+-CaM com- 
plexes, and (c) expansion of trichocyst content and fusion of 
trichocyst and plasma membranes in a coordinated fashion, to 
result in release of the fully expanded trichocyst matrix. 
Observations on the swimming behavior of Paramecia  ex- 
posed to TFP suggest that cytoplasmic Ca  2+ increases following 
exposure to CaM antagonists. Paramecium exposed to  10-15 
gM TFP or 40 gM W-7 exhibit a slowing of forward swimming 
(35a), which is indicative of a rise in cytoplasmic Ca  2+ concen- 
tration from  10 -7  M  to the vicinity of l0  -s M  (32).  Therefore 
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it would appear that CaM antagonists are capable of inhibiting 
trichocyst matrix expansion even when cytoplasmic Ca  2+ con- 
centration is elevated, suggesting that the effect of the CaM 
antagonists is after Ca  2+ entry. 
Of the events following the rise in intracellular Ca  2+ concen- 
tration, matrix expansion is clearly TFP sensitive. Matrix ex- 
pansion requires Ca  2+ and can be induced in isolated organelles 
in vitro by simple addition of this ion (4,  11). In vivo, sponta- 
neous  trichocyst expansion  is presumably prevented  by the 
trichocyst membrane,  which  prevents  access of Ca  2+  to  the 
matrix. Upon stimulation, Ca  2+ must enter the trichocyst vesicle 
to induce expansion and can do so via two possible routes: (a) 
through the trichocyst membrane which, following stimulation, 
is made permeable to Ca2+;  or (b)  from the  outside via the 
exocytic opening created by the fusion of trichocyst and plasma 
membranes. While the second alternative probably contributes 
to  the  Ca  2+  flux  involved in  expansion,  it does  not  appear 
necessary, at least in the early stages of trichocyst expansion 
seen following fixation, the stage I to stage II transition. When 
the tips of expanded (stage II) trichocysts can be viewed in 
favorable sections, most of them do not have fused membranes. 
Indeed, partially expanded trichocysts (stage II) are common, 
whereas  fusion  profiles are  rarely seen.  These  observations 
suggest that the route of Ca  2+ into the trichocyst vesicle follow- 
ing  fLxation is  across the  trichocyst membrane,  but  do  not 
preclude that in vivo membrane fusion may occur prior to or 
concurrent with expansion. 
The next question is whether TFP inhibits matrix expansion 
by blocking this Ca  2+ flux across the trichocyst membrane, or, 
alternatively, whether the inhibition is due to a direct interac- 
tion  of TFP with  the matrix itself?. This latter possibility is 
especially important to consider in light of a recent report that 
CaM  comprises  a  significant  percentage  of the  protein  of 
extruded trichocyst matrices (38).  In vitro studies on isolated, 
membrane-free, condensed trichocysts (stage I) in our labora- 
tory suggest that TFP as well as other CaM antagonists appear 
not to inhibit the Ca2÷-induced matrix expansion (11,  13). The 
lack of an inhibitory effect in vitro may suggest that a  com- 
ponent(s) conferring drug sensitivity in vivo is lost during the 
isolation procedure.  These  may be  cytoplasmic components 
involved in stimulus-secretion coupling, regulatory components 
associated with  the  matrix  itself,  or  possibly the  trichocyst 
membrane,  absent  from  the  isolated organelle,  which  may 
regulate Ca  2+ access to the trichocyst matrix in a CaM-depend- 
ent  manner.  Another  potential  site  for  CaM  regulation  is 
suggested by a recent report which correlates a Ca2+-dependent 
dephosphorylation with secretion in these cells (14). 
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